Sunshine Biopharma, Inc. SBFM
Rating
Rating Factors
Company Overview
Sunshine Biopharma, Inc. is a pharmaceutical and healthcare company focused on the development and commercialization of oncology and antiviral therapeutics, as well as the distribution of generic pharmaceuticals. The company operates primarily in the biotechnology and pharmaceutical industries through a combination of drug development activities and commercial pharmaceutical distribution operations. Its revenue base has increasingly been driven by its generic pharmaceutical distribution business, while its biotechnology pipeline remains focused on proprietary drug candidates targeting cancer and viral diseases.
The company evolved from an early-stage biotechnology enterprise into a broader pharmaceutical platform through strategic expansion into generic drug distribution. Sunshine Biopharma has highlighted proprietary research programs involving anticancer compound development and antiviral platform technologies, while also pursuing commercial scale through acquisitions and operational expansion. Its positioning combines higher-risk biotechnology research activities with cash-flow-oriented pharmaceutical distribution operations intended to diversify revenue sources and operational exposure.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $0.67
- Current
- $0.67
- High
- $24.30
Valuation
Dividends and Shares
Corporate Info
CU4 Suite 433
Fort Lauderdale, FL 33301